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INTRODUCTION
The  association  of  myasthenia  gravis  (MG)  with
thymoma is about 15%, which increases to about 35%
in older patients (1,19).  Thymomas represent nearly
50% of tumors in the anterior mediastinum and if large
enough  may  cause  mediastinal  widening  (12).    The
connection between the thymus gland and MG has led
to  the  medical  recommendation  of  a  thymectomy,
however,  a  thymectomy  does  not  cure  MG  but  may
significantly decrease the symptoms in 90% of patients
with MG (13).  If a female between the ages of 20-30 or
a male older than 60 complains of generalized fatigue,
eye  muscle  weakness,  dysphagia,  dystonia,  and/or
dysarthria  MG  should  be  considered  and  thymoma
ruled out (1, 3, 4).  This case report provides detailed
descriptions and illustrations of how to recognize and
treat  MG,  the  importance  of  investigating  for  a
thymoma,  and  current  information  regarding  a
thymectomy. Overall, even though evidence has shown
the correlation between MG with thymoma, this case
report depicts how a patient may present with multiple
complaints yet specific to the diagnoses illustrating the
importance  of  conducting  a  thorough  history  and
physical.   
CASE PRESENTATION 
A 57-year-old Caucasian male with no known past
medical history came into the Emergency Department
complaining of progressively worsening dizziness, jaw
weakness,  difficulty  swallowing,  and  left  eyelid
drooping for one-to-two weeks.  Also, the patient stated
that he was unable to continuously chew his food and
had  to  take  breaks  in  order  to  finish  his  meals.  In
addition,  he  complained  of  sporadic  episodes  of
blurriness and double vision for at least three months.
He denied trauma, falling and/or febrile illnesses prior
to his current symptoms.  Upon further questioning, the
patient stated that his voice had recently changed to a
nasal tone.  He did not seek medical attention earlier in
hopes that his symptoms would spontaneously resolve.  
Past medical history was unremarkable. Past surgical
history  included  a  tonsillectomy  at  the  age  of  12,
bilateral reconstructive mastoid surgery at the age of 16
with  a  revision  surgery  shortly  after  for  left  facial
paralysis caused by a compressed facial nerve.  
Family history included his mother who had diabetes
and  passed  away  from  end  stage  renal  disease.  The
patient’s father died at the age of 91 with no known
morbidities.    His  brother  and  sister  both  suffer  from
diabetes and hypertension. There are no known cancers
or neurological disorders within his family. 
The  patient  used  to  work  in  construction  and
frequently used a jackhammer.  He currently works at a
flea market moving and lifting heavy merchandise. He
lives alone and has been separated from his wife for
three months. He has three healthy children.  He has no
history of cigarette smoking or intravenous drug abuse
and  occasionally  drinks  alcohol  within  a  social
atmosphere.    He  reports  no  history  of  recent  travel,
camping  or  hiking.  The  patient  was  not  taking  any
medications.    His  only  allergy  was  penicillin  that
resulted in a rash.   
Review  of  symptoms  included  intermittent
occurrences  of  difficulty  speaking,  chewing  and
swallowing,  slowed  thinking  process,  and  a  constant
nasal  tone  in  his  voice  for  one-to-two  weeks.
Additionally, the patient complained of double vision
and left sided earache for three months.  When asked
about  the  current  symptoms  the  patient  gave
inconsistent information and said that he feels fatigued 
most of the time and his symptoms got worse as the day 
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progressed  but  improved  with  rest.    Prior  to  this
current illness his appetite was fine.  He further denied
weight changes, shortness of breath, chest pain, back
pain, bowel or bladder incontinence, and skin rashes.
Physical  examination  revealed  a  middle-aged
moderately built and well-nourished Caucasian male in
no apparent distress with bilateral ptosis.  Vital signs
were normal.  Pupils were equal but slowly reactive to
light.  The patient was unable to look upwards and noted
to have bilateral vertical gaze palsy.  When directed to
move his eyes lateral, the right could move more than
the left yet they were both delayed.  The rest of the Head
and Neck examination was normal. Face examination
showed  a  slightly  less  prominent  left  nasolabial  fold
compared  to  the  right,  and  bilateral  facial  muscle
weakness was appreciated when frowning or smiling.
There was no tongue or uvula deviation found.  The
cardiovascular,  pulmonary,  abdominal  examination,
extremities, rectal and prostate exam was normal. The
neurological  examination  revealed  a  patient  that  was
alert  and  oriented  to  person,  place  and  time.    In  all
extremities, the motor examination was 4+/5 and deep
tendon reflexes were 2+.  The patient had a strong gag
reflex.  As noted above, cranial nerves two, three, five,
six,  and  seven  were  affected.   The  patients  gait  was
intact, no instability noted, and the cerebellum and its
reflexes were intact.
The  differential  diagnoses  in  this  case  were  MG,
botulism, multiple sclerosis and/or a brain stem infarct.
An important feature to differentiate MG from botulism
is upon examination of pupils. In MG accommodation
of  the  pupils  is  usually  spared,  whereas  botulism
presents  with  impaired  accommodation  and
gastrointestinal  symptoms  simultaneously  (21.).
Multiple  sclerosis  and  brain  stem  infarct  requires
objective evidence of neurologic signs that are localized
to the brain or spinal cord which were absent in our
patient.
The  laboratory  values  regarding  a  complete  blood
count, basic metabolic panel, liver function test, thyroid
function test, lipoproteins, triglycerides, urine analysis,
and urine culture were all within normal limits.  
In regards to the patients’ symptoms, he was admitted
with  a  diagnosis  of  weakness  secondary  to  possible
myasthenia  gravis.    His  treatment  began  with  oral
Prednisone  and  oral  pyridostigmine.  A  medical
nutritional  therapy  consult  recommended  a  modified
mechanical  soft  diet  secondary  to  complaints  of
dysphagia. 
On this same day of admission, a lumbar puncture was
done  with  a  cerebral  spinal  fluid  (CSF)  cell  count,
differential,  culture,  protein  and  glucose  amount
measured to be within normal limits with exception of
the  CSF  having  a  high  red  blood  cell  count  of  34
cells/centimeter
3 (normal is zero).  In addition, the CSF
was negative for oligoclonal bands. These CSF result
made  the  diagnosis  of  CNS  disorders  such  as  the
Guillain-Barre  Syndrome  and  Multiple  Sclerosis  less
likely.  Chest  x-ray  showed  anterior  mediastinal
widening  with  left  basilar  subsegmental  atelectasis.
There  was  also  a  mild  elevation  of  the  left
hemidiaphragm and minor degenerative changes of the
thoracic  spine.  Computed  tomography  (CT)  without
contrast  of  the  head  showed  no  acute  intracranial
abnormalities.    The  CT  impression  concluded  an
anterior  mediastinal  mass  measuring  approximately
seven centimeters (cm) in length by four cm in diameter
with  irregular  calcifications  (Figure  1).  However,
malignancy was neither ruled in nor ruled out.  At this
point, the likely diagnosis was a thymoma.  
Nerve conduction studies and electromyography were
completed which revealed findings most consistent with
a  postsynaptic  neuromuscular  junction  transmission
disorder.  The acetylcholine receptor antibodies were
positively  elevated  at  116.3  nanomoles/liter  (nmol/L)
(reference range < 0.1).  At this point, myasthenia gravis
was the confirmed diagnosis and the plan was to remove
the thymus gland and keep the patient on Prednisone
and pyridostigmine throughout the hospital stay. 
On the fifth day of admission, the patient underwent
an uncomplicated thymectomy.  The surgeons used a
median  sternotomy  approach  to  dissect  the  thymus
gland.  Pathology reported both gross and microscopic
descriptions of the isolated thymus. The findings were
consistent with the World Health Organization (WHO)
type B3 with involvement of minimal invasion.  The
neoplasm  was  not  present  at  the  surgical  resection
margins.  
During  the  remainder  of  the  hospital  course
Prednisone was continuously tapered down to prevent
wound  dehiscence,  a  five-day  course  of  intravenous
immunoglobulins was administered. Furthermore, there
were  marked  improvements  noted  in  the  tone  of  the
facial muscles bilaterally.  Significant improvements in
the  symptoms  of  weakness  and  dysphagia  were  also
found.    
On postoperative Day 10, an acetylcholine receptor
binding test showed a significant decrease compared to
the preoperative measurement (116.3 nmol/L and 33.3
nmol/L, respectively). The patient was discharged on
postoperative day 13 with pyridostigmine, a tapering
dose of Prednisone, and vitamin A for 14 days.   
Follow-ups  two  years  postoperatively  have  shown
significant improvements on clinical examination. The
patient has been monitored closely on low dose steroids
and  pyridostigmine  and  has  only  reported  minor
symptoms of MG.        20 Weakness and Weakening
DISCUSSION
Myasthenia gravis (MG) is an autoimmune disorder
and  neuromuscular  disease  with  characteristic
symptoms  of  unpredictable  and  irregular  bouts  of
muscle weakness and fatigability (1).  MG is mediated
by  circulating  anti-acetylcholine  receptor  antibodies
that block acetylcholine receptors at the postsynaptic
neuromuscular  junction  (2).   A  characteristic  finding
associated with MG is a bimodal peak incidence that
usually occurs in females between the ages of 20 to 30
years and males greater than 60 years (3). The onset of
this disorder is often sudden with reports of intermittent
symptoms that become worse during periods of activity
and improve after periods of rest (1).  Feature signs and
symptoms include weakness in the muscles that control
eye and eyelid movements (ocular myasthenia), facial
expression, chewing, swallowing (dysphagia), slurred
speech (dysarthria) that is often associated with a nasal
tone (dystonia) due to weakness of the velar muscles,
and generalized muscle weakness that may involve the
extremities and trunk (4).  Ocular myasthenia symptoms
vary  in  severity  but  usually  include  asymmetrical
drooping  of  one  or  both  eyelids  (ptosis)  and  double
vision (diplopia).  In fact it is these two symptoms that
are usually first reported by patients with MG (5). It is
also worth mentioning that the occurrence of dysphonia
and  dysphagia  are  found  to  be  the  first  symptoms
related  to  late-onset  MG  (6).    In  severe  cases,  the
muscles  that  control  respiration  can  be  affected
(myasthenia  crisis),  and  when  this  happens  assisted
ventilation is often required to sustain life (6, 20).  In
patients  whose  respiratory  muscles  are  already  weak
crisis  may  be  triggered  by  infection,  fever,  or  by  an
adverse reaction to a medication (6). 
Diagnosis  of  MG  is  based  on  a  thorough  physical
examination,  clinical  testing,  serologic  testing,  and
imaging studies to rule out the commonly associated
thymoma.  In addition to the signs and symptoms as
described above, other examinations that may facilitate
the diagnosis of MG include applying ice to fatigued
muscles to observe a characteristic increase in strength,
and by performing and monitoring the following tests to
observe the muscle fatigability (8).
Clinical testing may involve the Edrophonium test,
electromyography,  and/or  in  severe  cases,  pulmonary
function tests.  The Edrophonium test is valuable when
the  diagnosis  of  MG  is  unconfirmed.    This  test  is
positive if there is increased muscle strength (especially
observed  in  the  eyes)  after  the  administration  of
intravenous  edrophonium  chloride  or  neostigmine,
drugs  that  temporarily  increase  the  amount  of
acetycholine  at  the  neuromuscular  junction  (9).  Side
effects associated with this test are usually mild (such as
urinary or fecal incontinence and excessive salivation).
Severe  bradycardia  and  bronchoconstiction  are  rare
risks  associated  with  this  test  but  can  happen  if
parasympathetic supply of the cardiopulmonary system
becomes over active. It is because of these effects closer
cardiac  monitoring  is  advised  while  performing  this
test.  Also  Edrophonium  administration  should  be
performed  in  a  setting  where  immediate  ventilatory
support can be provided if needed. On the other hand,
electromyography is considered to be one of the most
sensitive tests in diagnosis of MG.  Electromyography
measures muscle fatigability by stimulating repetitive
electrical impulses to muscle fibers (8).      
Serologic testing is effective in testing the blood for
antibodies  against  the  acetylcholine  receptor.    It  has
been found that approximately 80% of people with MG
have  increased  serum  antibodies  to  the  acetylcholine
receptor and the remaining 20% have antibodies to the
muscle specific kinase (10).
Imaging studies are usually taken in patients with MG
because studies have found the association of MG with
thymoma to be about 15%, and 35% in older patients
(Brachmann K, 1).  A thymoma is considered a rare
tumor of the thymus gland that is usually benign but
when  it  becomes  malignant  it  is  extremely  invasive
(11).  Thymomas represent about 50% of tumors in the
anterior  mediastinum  and  may  grow  in  size  and
eventually squeeze blood vessels, the heart and/or lungs
(12).  The  connection  between  the  thymus  gland  and
MG  has  led  to  the  medical  recommendation  of  a
thymectomy.  However, a thymectomy does not cure
MG but may significantly decrease the symptoms of
MG in 90% of patients (13).  
The  value  of  thymectomy  is  dependent  on  a  high
proportion of B-lymphocytes and the germinal center
B-lymphocytes in the thymus, suggesting that one of the
biological roles of thymectomy in the treatment of MG
is  removing  the  thymus-associated  germinal  centers
(14).  Although the thymus is the central organ for T-
lymphocyte differentiation, the germinal center is where
2009
Signs Description
Shifting Ptosis Quickly fluctuating droop of the eye
lids which is usually asymmetric. 
Curtain Sign Ptosis is enhanced if the patient
keeps one eye open by holding it,
this leads  the other eye to droops
more ( like a curtain)
Lid Twitch
sign
Eye lid twitch for fraction of a
second before settling when the eyes
are opened after gentle closure. 
Peek sign Upon tight closure of the eyes, the
lid margins start to separate to the
point that white of the sclera
becomes visible.
Table 1: Specific sigs to elicit muscle fatigability21 Weakness and Weakening Vol. 12  No. 2
where  B-lymphocytes  differentiate  to  the  cells
producing  antibodies  (i.e.  acetylcholine  receptor
antibodies)  with  high  affinity  to  the  antigens.
Consistent with the improvement of clinical symptoms,
the anti-acetylcholine receptor antibody was shown to
decrease  following  thymectomy  (10).    With  that  in
mind, an anti-acetylcholine receptor antibody may be
considered  a  good  postoperative  indicator  of
improvement.    In  this  case,  all  the  symptoms
significantly decreased postoperatively as did the anti-
acetylcholine  receptor  antibodies  from  116  to  33.3
nmols/L.    
In the new WHO classification, the types of thymoma
are distinguished on histological criteria which seem to
be of independent prognostic significance: 1) type A
thymomas  (medullary  or  spindle-cell);  2)  type  AB
thymomas (mixed thymoma); 3) type B thymomas with
subclasses B1 (lymphocyte-rich), B2 (cortical) and B3
(epithelial,  atypical,  well-differentiated);  4)  type  C
(thymic  carcinomas).    Type  A  and  AB  are  usually
benign,  types  B1-B3  is  considered  low  to  moderate
malignant  neoplasms,  and  type  C  is  usually  highly
malignant (15).  Interestingly and not well analyzed was
a study that found type B3 thymomas, as presented in
this case, to show chromosomal imbalances with a gain
of 1q, loss of chromosome 6, and loss a of 13q (16). The
most  recent  WHO  classification  of  thymoma  has
acknowledged  that  surgical  resection  remains  the
mainstay of treatment for type B3 thymic tumors, and
radiation  and  chemotherapy  also  have  been  applied
widely as adjuvant and palliative procedures (17).  
Thymectomies  can  be  performed  using  several
surgical  approaches.    Ranging  from  most  to  least
invasive  is  the  full  median  sternotomy,  partial
sternotomy,  thoracoscopic,  and  transcervical
approaches  (18).    In  this  case,  the  full  median
sternotomy  approach  was  used  and  an  incision  was
made down the middle of the chest through the sternum
in  order  to  expose  the  enlarged  thymoma.    This
technique was chosen because CT of the chest showed
a massive widening of the anterior mediastinum, and
due to the size of the thymoma an invasive approach
was necessary.
The long-term results of patients who underwent a
thymectomy  for  MG  was  recently  studied  paying
special  attention  to  postoperative  disease-related
outcome, quality of life, and differences regarding the
operative approach.  Overall, this study concluded that
the  transsternal  thymectomy  contributed  to  an
improvement in MG symptoms for all subgroups, and
minimally invasive surgery was found to be superior in
terms  of  improvement  in  MG-associated  symptoms
(19).    Although  it  has  been  shown  that  removal  of
thymoma can be beneficial in MG, It is not clear if a
hyperplastic or normal thymic tissue should be removed
as some authors have concluded exacerbation of MG
with removal of hyperplastic or normal thymic tissue.
The details of this controversy are beyond the scope of
this article. Some authors have also shown that even
though thymoma removal has minimal effects on the
symptoms  progression,  it  should  still  be  removed
primarily for oncological purposes.
Thymectomy is only one component of the treatment
for  MG.    Medical  therapy  of  MG  may  also  include
anticholinesterase  inhibitors,  such  as  pyridostigmine,
and/or  immunosuppressive  medications,  such  as
corticosteroids,  plasmaphoresis  or  intravenous
immunoglobulin (20).  Postoperative worsening of MG
in this case was probably secondary to the thymectomy
and the patient having preexisting mild atelectasis, and
most  likely  not  due  to  an  excess  of  cholinergic
medications.  However, cholinesterase inhibitors should
be  stopped  when  myasthenia  crisis  (respiratory  and
pharyngeal  muscle  paralysis)  is  suspected  because  it
may  be  difficult  to  distinguish  between  myasthenia
crisis  versus  cholinergic  crisis.    Regardless,  patients
may require prolonged mechanical ventilatory support,
and as seen in this case, elective intubation following
surgery.  Alternatively, medications known to worsen
MG symptoms include D-penicillamine, neuromuscular
blocking agents, quinidine, aminoglycoside antibiotics,
beta-blockers,  calcium  channel  blockers,  magnesium
salts, and iodinated contrast agents (20). Therefore, a
careful review of a patient’s medication regime with
other co-morbidities is imperative.   
CONClUSION
When the signs and symptoms of MG are suspected
and  imaging  studies  reveal  widening  of  the  anterior
mediastinum it is important to know that a thymoma
may  represent  about  50%  of  tumors  in  the  anterior
mediastinum (12).  A thymectomy may not cure MG but
may  significantly  decrease  the  symptoms  (13),  and
further prevent the rapid conversion of a benign tumor
into a highly invasive tumor (11).  Testing the blood for
antibodies against the acetylcholine receptor before and
after  a  thymectomy  may  assist  in  the  diagnosis  and
treatment of patients with MG (10). The prognosis of a
patient with MG who undergo a thymectomy has not
been studied thoroughly as there are some discrepancies
regarding  remission  and  recurrence  rates,  however
having a thymectomy has shown a better outcome than
not having one (19).
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